# CLD-ML-Pipeline

Simulation-driven clone selection framework for Cell Line Development (CLD)

## Vision

Cell Line Development (CLD) remains one of the most resource-intensive stages in biologics manufacturing.
Despite advances in AI for drug discovery, predictive modeling for biomanufacturing platforms is still underdeveloped.

This project aims to build a Simulation-Driven Laboratory (SDL) framework for CLD, enabling:
	â€¢	Early-stage clone ranking
	â€¢	Late-stage outcome prediction
	â€¢	Multi-objective decision simulation
	â€¢	Platform engineering scenario testing

The long-term goal is to reduce CLD time, cost, and experimental burden using predictive modeling.

## Concept

We simulate a realistic CLD process including:
	â€¢	Clone-to-clone productivity variability (log-normal)
	â€¢	Stability-driven productivity decay
	â€¢	Expression burden effects
	â€¢	Stress accumulation
	â€¢	Aggregation (quality proxy)
	â€¢	Batch effects
	â€¢	Culture mode differences (fed-batch vs perfusion)
	â€¢	Copy number (ddPCR-like)
	â€¢	Platform factor (targeted integration vs legacy)
	â€¢	Clone-specific decay heterogeneity

The framework allows:

Early data (passages 3â€“10) â†’ Late prediction (passages 24â€“30)

## Project Architecture

Synthetic DB Generation
        â†“
Feature Engineering (Early-only)
        â†“
Multi-target ML Models
        â†“
Ranking & Top-K Evaluation
        â†“
Decision Simulation (Retention %)
        â†“
Platform Scenario Testing

## Repository Structure

data/
    schema/
    synthetic/
        raw/
        processed/

notebooks/
    01_explore_synthetic_data.ipynb
    02_feature_engineering.ipynb
    02d_feature_engineering_v2.ipynb
    02c_build_late_labels.ipynb
    03b_multitarget_models.ipynb
    04_clone_drop_simulation.ipynb
    04b_predicted_late_selection.ipynb

src/
    data_generation/
        generate_synthetic_cld.py

## Synthetic Data Generator

The generator simulates:

**Latent variables per clone:**
	â€¢	Productivity (P)
	â€¢	Stability (S)
	â€¢	Quality potential (Q)
	â€¢	Platform factor (G)
	â€¢	Copy number (CN)
	â€¢	Clone-specific decay sensitivity (k_decay_i)

**Assays:**
	â€¢	Titer
	â€¢	VCD
	â€¢	Viability
	â€¢	Aggregation
	â€¢	ddPCR copy number

**Derived label:**
	â€¢	Productivity drop % (early vs late)

The generator supports scenario switches:
enable_platform=True
enable_copy_number=True
enable_clone_decay_variation=True

This allows ablation and sensitivity analysis.

## ðŸ“ˆ Modeling Strategy

We train 3 regression models:
	1.	Stability drop
	2.	Late-stage titer
	3.	Late-stage aggregation

Evaluation includes:
	â€¢	RÂ²
	â€¢	MAE
	â€¢	Spearman rank correlation
	â€¢	Top-K overlap
	â€¢	Top-K enrichment rate

## ðŸŽ¯ Multi-Objective Selection

We simulate commercial clone selection using:

Utility = a*z(late_titer)
        - b*z(drop)
        - c*z(late_aggregation)

We evaluate:
	â€¢	Top 5 / 10 / 20 retention
	â€¢	True-good recall
	â€¢	Ranking robustness

## Platform Scenario Modeling

The framework supports comparison between:
	â€¢	Legacy random integration
	â€¢	Targeted integration platform
	â€¢	High-copy unstable clones
	â€¢	Optimized secretion pathway

This allows:

Testing whether platform engineering improves early predictability.

## Scientific Foundations

This work is informed by:
	â€¢	Reinhart et al., Biotechnol J (2018)
	â€¢	Lakshmanan et al., Biotechnol Bioeng (2019)

Multi-omics evidence shows host-specific behavior and complex regulation of productivity and quality.

## Key Insight

Early â†’ Late prediction is inherently difficult due to:
	â€¢	Epigenetic silencing
	â€¢	Stress accumulation
	â€¢	Secretion bottlenecks
	â€¢	Platform effects
	â€¢	Stochastic events

Therefore, the goal is not perfect prediction, but:

Enrichment improvement under uncertainty.

## Future Directions
	â€¢	Multi-omics integration
	â€¢	Glycosylation modeling
	â€¢	Secretory capacity modeling
	â€¢	Platform upgrade simulation
	â€¢	Automated weight tuning (policy optimization)
	â€¢	Real CLD dataset validation
	â€¢	Robotic integration

## Current Status

âœ” Synthetic CLD simulator
âœ” Multi-target ML modeling
âœ” Ranking evaluation framework
âœ” Platform scenario switches
âœ” Copy number integration
âœ” Decision simulation engine

Ongoing work:
	â€¢	Improve early â†’ late signal strength
	â€¢	Platform scenario calibration
	â€¢	Advanced ranking metrics

## Authorâ€™s Motivation

This project originates from real CLD experience in biologics manufacturing and aims to bridge AI modeling with upstream bioprocess engineering.

## License
Apache License 2.0
